CARYN CHISHOLM: Open Payments
NPI 1922522275 · PEORIA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$322 in 15 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $322
Food & beverage: $322
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $76 |
| Otsuka America Pharmaceutical, Inc. | 2 | $57 |
| E.R. Squibb & Sons, L.L.C. | 3 | $53 |
| Vanda Pharmaceuticals Inc. | 2 | $48 |
| Janssen Pharmaceuticals, Inc | 2 | $31 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
| Alkermes, Inc. | 1 | $16 |
| Lundbeck LLC | 1 | $15 |
Products named: ABILIFY ASIMTUFII, INGREZZA, COBENFY, FANAPT, INVEGA SUSTENNA, UZEDY, ARISTADA.
Industry payments across AZ — which companies pay providers there.
